CirTran Q2 Sales Surge 596% but Going Concern Warning Persists
CIRX has more than doubled off its 52-week low of $0.005.
Summary
CirTran reported a 596% revenue surge in Q2 2026 and an operating profit, but the going concern warning, ineffective controls, and massive potential dilution from convertible debt keep the outlook highly uncertain.
Key Events · Earnings and Guidance · CIRX
-
Q2 Revenue Surges 596%
Net sales for Q2 2026 were $1,171,666, up from $168,435 in Q2 2025, driven by increased demand for vapor products.
-
Operating Profit Achieved
Income from operations was $160,628 for Q2 2026, compared to a loss of $193,258 in the prior-year quarter.
-
Going Concern Warning Reiterated
Cash of $158,137, working capital deficit of $20.3 million, and accumulated deficit of $60.2 million raise substantial doubt about the company's ability to continue as a going concern.
-
Disclosure Controls Ineffective
Management concluded that disclosure controls and procedures were not effective as of June 30, 2026.
Analysis · CIRX · Manufacturing
CirTran's Q2 revenue jumped to $1.17 million from $168,435 a year ago, driven by vapor product demand, and the company swung to an operating profit of $160,628. However, the company still has only $158,137 in cash, a $20.3 million working capital deficit, and management reiterates substantial doubt about its ability to continue as a going concern. The filing also reveals that disclosure controls are ineffective and that convertible debentures could require issuing 230 million shares, far exceeding the 100 million authorized, creating massive potential dilution.
At the time of this filing, CIRX was trading at $0.04 on OTC in the Manufacturing sector, with a market capitalization of approximately $207.7K. The 52-week trading range was $0.00 to $0.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.